Maryland Medical Cannabis Commission Policy Committee Meeting Minutes September 7, 2017 2:00 pm Winchester Hall, 1st Floor Meeting Room 12 East Church Street, Frederick, Maryland 21701 Commissioners Present: J. Charles Smith (Chairman) Rachel Rhodes James Pyles Brian Lopez (Chairman of Commission) Commissioners Present by Telephone: Charles LoDico Commissioners Absent: Barry Pope Staff Present: Patrick Jameson, Executive Director Heather Nelson, Assistant Attorney General Lori Dodson, Director of Compliance for Independent Testing Laboratories Mary-jo Mather, Director of Administration Myesha McQueen, Administrative Specialist Kristen Shreves, Quality Assurance Specialist Ideai Gray, Quality Assurance Specialist Call to Order Chairman called the meeting to order at 2:07 pm and welcomed the attendees. Chairman Smith introduced the members of the Policy Committee. A quorum was achieved. Approval of Minutes Chairman asked if Commissioners had time to review the draft minutes of the May 22, 2017 meeting and if there were any comments. He asked for a motion to approve the minutes. The motion was offered by Commissioner LoDico and seconded by Commissioner Pyles. The May 22, 2017 Minutes were approved unanimously. Message from Executive Director Executive Director Patrick Jameson began by welcoming the Commissioners to the Policy Committee Meeting. Mr. Jameson explained that at this Policy Committee meeting the
(3) Revise the status of the lot in the inventory control. If a licensed processor receives test results that the lot does not meet specifications, the licensed processor may rework or reprocess the lot according to standard operating procedure. The reworked or reprocessed lot be resampled and retested by the Independent Testing Laboratory to meet all required specifications. A licensee shall retain every certificate of analysis. New: Section has been Renumbered to .04 If a licensed processor, upon review of the certificate of analysis, determines that a lot meets the specification for the product, the licensed processor may: Assign an expiration date to the lot; Release the lot for distribution; and Revise the status of the lot in the inventory control. If a licensed processor receives test results that the lot does not meet specifications, the licensed processor may: Rework or reprocess the lot according to standard operating procedure; Provide the reworked or reprocessed lot to the Independent Testing Laboratory to be resampled and reanalyzed; and If upon review of the subsequent certificate of analysis, determines that the lot the specifications for reworked and reprocessed medical cannabis products, Assign an expiration date to the lot; Release the lot for distribution as reworked or reprocessed medical cannabis product; and Revise the status of the lot in the inventory control. A licensed processor shall retain every certificate of analysis. Chairman Smith asked for a motion to adopt proposed draft revisions to Chapter 23 to include Independent Testing Laboratory Selection and Requirements, Contents of Certificate of Analysis, and Reworking or Reprocessing a Lot. This motion was offered by Commissioner LoDico and seconded by Commissioner Pyles. The Committee voted unanimously to adopt the proposed revisions to Chapter 23. Adjournment After querying Commissioners as to any New Business and receiving no response, Chairman Smith asked for a Motion to Adjourn which was offered by Commissioner LoDico, and appropriately seconded by Commissioner Pyles. The meeting adjourned at 2:42 pm.